Cargando…

Impact of molecular profiling on overall survival of patients with advanced ovarian cancer

OBJECTIVE: Patients with recurrent epithelial ovarian cancer (EOC) have limited treatment options. Studies have reported that biomarker profiling may help predict patient response to available treatments. This study sought to determine the value of biomarker profiling in recurrent EOC. RESULTS: Pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herzog, Thomas J., Spetzler, David, Xiao, Nick, Burnett, Ken, Maney, Todd, Voss, Andreas, Reddy, Sandeep, Burger, Robert, Krivak, Thomas, Powell, Matthew, Friedlander, Michael, McGuire, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991422/ https://www.ncbi.nlm.nih.gov/pubmed/26942886 http://dx.doi.org/10.18632/oncotarget.7835

Ejemplares similares

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
por: Sjoquist, Katrin M., et al.
Publicado: (2018)

Impact of the Area of Residence of Ovarian Cancer Patients on Overall Survival
por: Jochum, Floriane, et al.
Publicado: (2022)

Identification of key gene signatures for the overall survival of ovarian cancer
por: Pawar, Akash, et al.
Publicado: (2022)

A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling service
por: Russell, Kenneth, et al.
Publicado: (2014)

PARP Inhibitors in Ovarian Cancer: A Review
por: O’Malley, David M., et al.
Publicado: (2023)

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival
por: Cardillo, Nicholas, et al.
Publicado: (2021)

Ferroptosis-Related Gene Model to Predict Overall Survival of Ovarian Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2021)

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
por: Lux, Michael Patrick, et al.
Publicado: (2021)

Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
por: Cheng, Hao, et al.
Publicado: (2023)

Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer
por: Muqaku, Besnik, et al.
Publicado: (2020)

Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study
por: Majidi, Azam, et al.
Publicado: (2023)

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies
por: Xiu, Joanne, et al.
Publicado: (2016)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
por: Halon, Agnieszka, et al.
Publicado: (2011)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer
por: Zhang, Xue-ying, et al.
Publicado: (2021)

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
por: Gong, Xiao-Qin, et al.
Publicado: (2022)

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
por: Haas, Michael, et al.
Publicado: (2017)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Primary ovarian cancer chemotherapy: current standards of care
por: McGuire, W P, et al.
Publicado: (2003)

Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer
por: Korsunsky, Ilya, et al.
Publicado: (2017)

Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival
por: Rastogi, Kartick, et al.
Publicado: (2018)

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
por: Köhler, Michael, et al.
Publicado: (2019)

The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
por: Blechschmidt, K, et al.
Publicado: (2008)

A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer
por: Chiang, An Jen, et al.
Publicado: (2014)

Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer
por: Jia, Peng, et al.
Publicado: (2017)

An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
por: Zhang, Liuyan, et al.
Publicado: (2019)

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival
por: Engqvist, Hanna, et al.
Publicado: (2018)

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
por: Nizam, Aaron, et al.
Publicado: (2019)

Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
por: Hoskins, Ebony R., et al.
Publicado: (2011)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
por: Chen, Qian, et al.
Publicado: (2020)

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials
por: Friedlander, Michael L., et al.
Publicado: (2016)

Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study
por: Tian, C, et al.
Publicado: (2014)

Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer
por: Grinstead, Christina, et al.
Publicado: (2022)

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
por: Ledermann, J.A., et al.
Publicado: (2021)

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
por: Sostelly, Alexandre, et al.
Publicado: (2019)

A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer
por: Ding, Qi, et al.
Publicado: (2020)

Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients
por: Shang, Hui, et al.
Publicado: (2021)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gf5n7kbcb7pfk0ol35lai7l8v7